
BPMC
Marshall Wace’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.09M | Buy |
31,900
+21,300
| +201% | +$2.73M | ﹤0.01% | 1143 |
|
2025
Q1 | $938K | Sell |
10,600
-151,282
| -93% | -$13.4M | ﹤0.01% | 1704 |
|
2024
Q4 | $14.1M | Sell |
161,882
-171,885
| -51% | -$15M | 0.02% | 616 |
|
2024
Q3 | $30.9M | Sell |
333,767
-17,989
| -5% | -$1.66M | 0.04% | 348 |
|
2024
Q2 | $37.9M | Buy |
351,756
+121,464
| +53% | +$13.1M | 0.05% | 301 |
|
2024
Q1 | $21.8M | Buy |
+230,292
| New | +$21.8M | 0.03% | 425 |
|
2023
Q1 | – | Sell |
-529,456
| Closed | -$23.2M | – | 2161 |
|
2022
Q4 | $23.2M | Buy |
+529,456
| New | +$23.2M | 0.05% | 353 |
|
2022
Q2 | – | Sell |
-186,600
| Closed | -$11.9M | – | 2713 |
|
2022
Q1 | $11.9M | Sell |
186,600
-764,082
| -80% | -$48.8M | 0.02% | 716 |
|
2021
Q4 | $102M | Buy |
950,682
+923,577
| +3,407% | +$98.9M | 0.19% | 95 |
|
2021
Q3 | $2.79M | Sell |
27,105
-11,981
| -31% | -$1.23M | 0.01% | 1070 |
|
2021
Q2 | $3.44M | Buy |
+39,086
| New | +$3.44M | 0.02% | 898 |
|
2021
Q1 | – | Sell |
-3,642
| Closed | -$408K | – | 2135 |
|
2020
Q4 | $408K | Sell |
3,642
-257,260
| -99% | -$28.8M | ﹤0.01% | 1422 |
|
2020
Q3 | $24.2M | Buy |
260,902
+238,042
| +1,041% | +$22.1M | 0.15% | 117 |
|
2020
Q2 | $1.78M | Sell |
22,860
-188,146
| -89% | -$14.7M | 0.01% | 807 |
|
2020
Q1 | $12.3M | Buy |
211,006
+204,103
| +2,957% | +$11.9M | 0.12% | 170 |
|
2019
Q4 | $553K | Buy |
+6,903
| New | +$553K | ﹤0.01% | 1090 |
|
2019
Q1 | – | Sell |
-8,635
| Closed | -$466K | – | 1711 |
|
2018
Q4 | $466K | Sell |
8,635
-139,699
| -94% | -$7.54M | ﹤0.01% | 1118 |
|
2018
Q3 | $11.6M | Buy |
+148,334
| New | +$11.6M | 0.1% | 275 |
|
2017
Q1 | – | Sell |
-30,302
| Closed | -$850K | – | 355 |
|
2016
Q4 | $850K | Buy |
+30,302
| New | +$850K | 0.01% | 774 |
|